A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

NCT07174336 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

920

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms
Neoplasm Metastasis

Interventions

DRUG: LY4064809
DRUG: Placebo
DRUG: Ribociclib
DRUG: Palbociclib
DRUG: Abemaciclib
DRUG: Anastrozole
DRUG: Letrozole
DRUG: Exemestane
DRUG: Fulvestrant

Sponsor

Eli Lilly and Company

Collaborators

[object Object]